← Back
$VTGN All transactions

Vistagen Therapeutics, Inc.

A

$ Value

$0

Shares

300,000

Price

$0

Filed

Jun 25

Insider

Name

Singh Shawn

Title

President and CEO

CIK

0001412071

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-23

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

300,000

Footnotes

Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date.

Filing Info

Accession No.

0001415889-25-018200

Form Type

4

Issuer CIK

0001411685

Singh Shawn's History

Date Ticker Type Value
2026-04-07 VTGN A $0
2026-04-07 VTGN A $0
2025-06-30 VTGN A $13K
2025-06-23 VTGN A $0

Other Insiders at VTGN (90d)

Insider Bought Sold Last
Singh Shawn
President and CEO
2026-04-07
Tressler Nick B.
Chief Financial Officer
2026-04-07
Adler Reid G.
Chief Legal Officer
2026-04-07
Prince Joshua S.
Chief Operating Officer
2026-04-07
Cote Elissa S.
Chief Corp Development Officer
2026-04-07